There should be a change in SOP parameters for evaluating FDCs: Dr RK Sanghavi Usha Sharma Mar 31, 2021 A sub-committee of DTAB has asked manufacturers of FDCs which were considered irrational by Prof Kokate Committee to present their…
Industry experts disagree with NPPA’s remark on FDCs Usha Sharma Nov 9, 2020 Experts say it is beyond the jurisdiction of NPPA
Delhi HC questions govt over urgency to ban over 300 FDC drugs Usha Sharma Apr 19, 2016 Additional Solicitor General was responding to the contentions of pharma companies like Pfizer, Glenmark, Procter and Gamble and…
